Loading...

David Tarin

TitleProfessor
InstitutionUniversity of California San Diego
DepartmentPathology
Address9500 Gilman Drive #0803
La Jolla CA 92093
Phone858-822-2081
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Todoric J, Antonucci L, Di Caro G, Li N, Wu X, Lytle NK, Dhar D, Banerjee S, Fagman JB, Browne CD, Umemura A, Valasek MA, Kessler H, Tarin D, Goggins M, Reya T, Diaz-Meco M, Moscat J, Karin M. Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas. Cancer Cell. 2017 Dec 11; 32(6):824-839.e8. PMID: 29153842.
      View in: PubMed
    2. Tarin D. Role of the host stroma in cancer and its therapeutic significance. Cancer Metastasis Rev. 2013 Dec; 32(3-4):553-66. PMID: 23625010.
      View in: PubMed
    3. Tarin D. Update on clinical and mechanistic aspects of paraneoplastic syndromes. Cancer Metastasis Rev. 2013 Dec; 32(3-4):707-21. PMID: 24052434.
      View in: PubMed
    4. Li N, Wu X, Holzer RG, Lee JH, Todoric J, Park EJ, Ogata H, Gukovskaya AS, Gukovsky I, Pizzo DP, VandenBerg S, Tarin D, Atay C, Arkan MC, Deerinck TJ, Moscat J, Diaz-Meco M, Dawson D, Erkan M, Kleeff J, Karin M. Loss of acinar cell IKKa triggers spontaneous pancreatitis in mice. J Clin Invest. 2013 May; 123(5):2231-43. PMID: 23563314; PMCID: PMC3635720.
    5. Ward KK, Tancioni I, Lawson C, Miller NL, Jean C, Chen XL, Uryu S, Kim J, Tarin D, Stupack DG, Plaxe SC, Schlaepfer DD. Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression. Clin Exp Metastasis. 2013 Jun; 30(5):579-94. PMID: 23275034; PMCID: PMC3622195.
    6. Yasunaga M, Manabe S, Tarin D, Matsumura Y. Tailored immunoconjugate therapy depending on a quantity of tumor stroma. Cancer Sci. 2013 Feb; 104(2):231-7. PMID: 23121194.
      View in: PubMed
    7. Tarin D. Clinical and biological implications of the tumor microenvironment. Cancer Microenviron. 2012 Aug; 5(2):95-112. PMID: 22782446; PMCID: PMC3399064.
    8. Tarin D. Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance. Cancer Metastasis Rev. 2012 Jun; 31(1-2):21-39. PMID: 22138779.
      View in: PubMed
    9. Yasunaga M, Manabe S, Tarin D, Matsumura Y. Cancer-stroma targeting therapy by cytotoxic immunoconjugate bound to the collagen 4 network in the tumor tissue. Bioconjug Chem. 2011 Sep 21; 22(9):1776-83. PMID: 21749132.
      View in: PubMed
    10. Shields DJ, Murphy EA, Desgrosellier JS, Mielgo A, Lau SK, Barnes LA, Lesperance J, Huang M, Schmedt C, Tarin D, Lowy AM, Cheresh DA. Oncogenic Ras/Src cooperativity in pancreatic neoplasia. Oncogene. 2011 May 05; 30(18):2123-34. PMID: 21242978; PMCID: PMC3104672.
    11. Tarin D. Cell and tissue interactions in carcinogenesis and metastasis and their clinical significance. Semin Cancer Biol. 2011 Apr; 21(2):72-82. PMID: 21147229.
      View in: PubMed
    12. Shields DJ, Niessen S, Murphy EA, Mielgo A, Desgrosellier JS, Lau SK, Barnes LA, Lesperance J, Bouvet M, Tarin D, Cravatt BF, Cheresh DA. RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia. Proc Natl Acad Sci U S A. 2010 Feb 02; 107(5):2189-94. PMID: 20080647; PMCID: PMC2836678.
    13. Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prévost N, Tarin D, Shattil SJ, Cheresh DA. An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med. 2009 Oct; 15(10):1163-9. PMID: 19734908; PMCID: PMC2759406.
    14. Montel V, Suzuki M, Galloy C, Mose ES, Tarin D. Expression of melanocyte-related genes in human breast cancer and its implications. Differentiation. 2009 Dec; 78(5):283-91. PMID: 19699574.
      View in: PubMed
    15. Leth-Larsen R, Lund R, Hansen HV, Laenkholm AV, Tarin D, Jensen ON, Ditzel HJ. Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol Cell Proteomics. 2009 Jun; 8(6):1436-49. PMID: 19321434; PMCID: PMC2690497.
    16. Tarin D. Comparisons of metastases in different organs: biological and clinical implications. Clin Cancer Res. 2008 Apr 01; 14(7):1923-5. PMID: 18381928.
      View in: PubMed
    17. Suzuki M, Mose E, Galloy C, Tarin D. Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts. Am J Pathol. 2007 Aug; 171(2):682-92. PMID: 17620367; PMCID: PMC1934534.
    18. Suzuki M, Tarin D. Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications. Mol Oncol. 2007 Sep; 1(2):172-80. PMID: 19383293.
      View in: PubMed
    19. Suzuki M, Mose ES, Montel V, Tarin D. Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. Am J Pathol. 2006 Aug; 169(2):673-81. PMID: 16877365; PMCID: PMC1698784.
    20. Montel V, Mose ES, Tarin D. Tumor-stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. Int J Cancer. 2006 Jul 15; 119(2):251-63. PMID: 16482564.
      View in: PubMed
    21. Erker L, Schubert R, Elchuri S, Huang TT, Tarin D, Mueller K, Zielen S, Epstein CJ, Wynshaw-Boris A. Effect of the reduction of superoxide dismutase 1 and 2 or treatment with alpha-tocopherol on tumorigenesis in Atm-deficient mice. Free Radic Biol Med. 2006 Aug 15; 41(4):590-600. PMID: 16863992.
      View in: PubMed
    22. Tarin D. New insights into the pathogenesis of breast cancer metastasis. Breast Dis. 2006-2007; 26:13-25. PMID: 17473363.
      View in: PubMed
    23. Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005 Jul 15; 65(14):5991-5; discussion 5995. PMID: 16024595.
      View in: PubMed
    24. Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 2005 Jul 15; 65(14):5996-6000; discussion 6000-1. PMID: 16024596.
      View in: PubMed
    25. Montel V, Huang TY, Mose E, Pestonjamasp K, Tarin D. Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am J Pathol. 2005 May; 166(5):1565-79. PMID: 15855655; PMCID: PMC1606408.
    26. Montel V, Pestonjamasp K, Mose E, Tarin D. Tumor-host interactions contribute to the elevated expression level of alpha1-antichymotrypsin in metastatic breast tumor xenografts. Differentiation. 2005 Mar; 73(2-3):88-98. PMID: 15811132.
      View in: PubMed
    27. Montel V, Kleeman J, Agarwal D, Spinella D, Kawai K, Tarin D. Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Res. 2004 Mar 01; 64(5):1687-94. PMID: 14996728.
      View in: PubMed
    28. Stuart RO, Wachsman W, Berry CC, Wang-Rodriguez J, Wasserman L, Klacansky I, Masys D, Arden K, Goodison S, McClelland M, Wang Y, Sawyers A, Kalcheva I, Tarin D, Mercola D. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc Natl Acad Sci U S A. 2004 Jan 13; 101(2):615-20. PMID: 14722351; PMCID: PMC327196.
    29. Goodison S, Kawai K, Hihara J, Jiang P, Yang M, Urquidi V, Hoffman RM, Tarin D. Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 1):3808-14. PMID: 14506175.
      View in: PubMed
    30. Hooper JD, Zijlstra A, Aimes RT, Liang H, Claassen GF, Tarin D, Testa JE, Quigley JP. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen. Oncogene. 2003 Mar 27; 22(12):1783-94. PMID: 12660814.
      View in: PubMed
    31. Hayashi K, Goodison S, Urquidi V, Tarin D, Lotan R, Tahara E. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4. Int J Oncol. 2003 Mar; 22(3):623-9. PMID: 12579317.
      View in: PubMed
    32. Agarwal D, Goodison S, Nicholson B, Tarin D, Urquidi V. Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model. Differentiation. 2003 Mar; 71(2):114-25. PMID: 12641565.
      View in: PubMed
    33. Kawai K, Viars C, Arden K, Tarin D, Urquidi V, Goodison S. Comprehensive karyotyping of the HT-29 colon adenocarcinoma cell line. Genes Chromosomes Cancer. 2002 May; 34(1):1-8. PMID: 11921276.
      View in: PubMed
    34. Euer N, Schwirzke M, Evtimova V, Burtscher H, Jarsch M, Tarin D, Weidle UH. Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines. Anticancer Res. 2002 Mar-Apr; 22(2A):733-40. PMID: 12014644.
      View in: PubMed
    35. Urquidi V, Sloan D, Kawai K, Agarwal D, Woodman AC, Tarin D, Goodison S. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin Cancer Res. 2002 Jan; 8(1):61-74. PMID: 11801541.
      View in: PubMed
    36. Taniyama K, Goodison S, Ito R, Bookstein R, Miyoshi N, Tahara E, Tarin D, Urquidi V. PTEN expression is maintained in sporadic colorectal tumours. J Pathol. 2001 Jul; 194(3):341-8. PMID: 11439367.
      View in: PubMed
    37. Schwirzke M, Evtimova V, Burtscher H, Jarsch M, Tarin D, Weidle UH. Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines. Anticancer Res. 2001 May-Jun; 21(3B):1771-6. PMID: 11497258.
      View in: PubMed
    38. Aogi K, Woodman A, Urquidi V, Mangham DC, Tarin D, Goodison S. Telomerase activity in soft-tissue and bone sarcomas. Clin Cancer Res. 2000 Dec; 6(12):4776-81. PMID: 11156234.
      View in: PubMed
    39. Woodman AC, Goodison S, Drake M, Noble J, Tarin D. Noninvasive diagnosis of bladder carcinoma by enzyme-linked immunosorbent assay detection of CD44 isoforms in exfoliated urothelia. Clin Cancer Res. 2000 Jun; 6(6):2381-92. PMID: 10873090.
      View in: PubMed
    40. Urquidi V, Tarin D, Goodison S. Role of telomerase in cell senescence and oncogenesis. Annu Rev Med. 2000; 51:65-79. PMID: 10774453.
      View in: PubMed
    41. Aogi K, Kitahara K, Urquidi V, Tarin D, Goodison S. Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid. Clin Cancer Res. 1999 Oct; 5(10):2790-7. PMID: 10537343.
      View in: PubMed
    42. Goodison S, Urquidi V, Tarin D. CD44 cell adhesion molecules. Mol Pathol. 1999 Aug; 52(4):189-96. PMID: 10694938; PMCID: PMC395698.
    43. Gorham H, Woodman A, Goodison S, Marsh J, Charnock M, Manek S, Sugino T, Tarin D. CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma. Mol Diagn. 1999 Mar; 4(1):45-56. PMID: 10229774.
      View in: PubMed
    44. Urquidi V, Tarin D, Goodison S. Telomerase in cancer: clinical applications. Ann Med. 1998 Oct; 30(5):419-30. PMID: 9814828.
      View in: PubMed
    45. Goodison S, Yoshida K, Churchman M, Tarin D. Multiple intron retention occurs in tumor cell CD44 mRNA processing. Am J Pathol. 1998 Oct; 153(4):1221-8. PMID: 9777953; PMCID: PMC1853036.
    46. Sugino T, Yoshida K, Zhao S, Goodison S, Tarin D. Disorderly CD44 gene expression in human cancer cells can be modulated by growth conditions. J Pathol. 1998 Sep; 186(1):17-23. PMID: 9875135.
      View in: PubMed
    47. Aogi K, Kitahara K, Buley I, Backdahl M, Tahara H, Sugino T, Tarin D, Goodison S. Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates. Clin Cancer Res. 1998 Aug; 4(8):1965-70. PMID: 9717826.
      View in: PubMed
    48. Goodison S, Tarin D. Clinical implications of anomalous CD44 gene expression in neoplasia. Front Biosci. 1998 Jul 01; 3:e89-109. PMID: 9634541.
      View in: PubMed
    49. Schwirzke M, Gnirke A, Bork P, Tarin D, Weidle UH. Differential gene expression in mammary carcinoma cell lines: identification of DRIM, a new gene down-regulated in metastasis. Anticancer Res. 1998 May-Jun; 18(3A):1409-21. PMID: 9673349.
      View in: PubMed
    50. Tokue Y, Matsumura Y, Katsumata N, Watanabe T, Tarin D, Kakizoe T. CD44 variant isoform expression and breast cancer prognosis. Jpn J Cancer Res. 1998 Mar; 89(3):283-90. PMID: 9600122.
      View in: PubMed
    51. Goodison S, Tarin D. Current status of CD44 variant isoforms as cancer diagnostic markers. Histopathology. 1998 Jan; 32(1):1-6. PMID: 9522209.
      View in: PubMed
    52. Sugino T, Yoshida K, Bolodeoku J, Tarin D, Goodison S. Telomerase activity and its inhibition in benign and malignant breast lesions. J Pathol. 1997 Sep; 183(1):57-61. PMID: 9370948.
      View in: PubMed
    53. Goodison S, Yoshida K, Sugino T, Woodman A, Gorham H, Bolodeoku J, Kaufmann M, Tarin D. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors. Cancer Res. 1997 Aug 01; 57(15):3140-4. PMID: 9242440.
      View in: PubMed
    54. Gorham H, Yoshida K, Sugino T, Marsh G, Manek S, Charnock M, Tarin D, Goodison S. Telomerase activity in human gynaecological malignancies. J Clin Pathol. 1997 Jun; 50(6):501-4. PMID: 9378818; PMCID: PMC499987.
    55. Bolodeoku J, Yoshida K, Sugino T, Churchman M, Woodman A, Goodison S, Tarin D. CD44 expression in human breast cancer cell lines is related to oestrogen receptor (ER) status and confluency in vitro. Biochem Soc Trans. 1997 May; 25(2):356S. PMID: 9191401.
      View in: PubMed
    56. Yoshida K, Sugino T, Tahara H, Woodman A, Bolodeoku J, Nargund V, Fellows G, Goodison S, Tahara E, Tarin D. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer. 1997 Jan 15; 79(2):362-9. PMID: 9010110.
      View in: PubMed
    57. Yoshida K, Sugino T, Goodison S, Warren BF, Nolan D, Wadsworth S, Mortensen NJ, Toge T, Tahara E, Tarin D. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer. 1997; 75(4):548-53. PMID: 9052409; PMCID: PMC2063304.
    58. Woodman AC, Sugiyama M, Yoshida K, Sugino T, Borgya A, Goodison S, Matsumura Y, Tarin D. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am J Pathol. 1996 Nov; 149(5):1519-30. PMID: 8909242; PMCID: PMC1865276.
    59. Sugino T, Gorham H, Yoshida K, Bolodeoku J, Nargund V, Cranston D, Goodison S, Tarin D. Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol. 1996 Sep; 149(3):873-82. PMID: 8780391; PMCID: PMC1865145.
    60. Sugino T, Yoshida K, Bolodeoku J, Tahara H, Buley I, Manek S, Wells C, Goodison S, Ide T, Suzuki T, Tahara E, Tarin D. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer. 1996 Aug 22; 69(4):301-6. PMID: 8797872.
      View in: PubMed
    61. Gorham H, Sugino T, Woodman AC, Tarin D. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa. J Clin Pathol. 1996 Jun; 49(6):482-8. PMID: 8763263; PMCID: PMC500539.
    62. Gorham H, Sugino T, Bolodeoku J, Yoshida K, Goodison S, Tarin D. Distribution of CD44 messenger RNA in archival paraffin wax embedded tumours and normal tissues viewed by in situ hybridisation. Clin Mol Pathol. 1996 Jun; 49(3):M147-50. PMID: 16696063.
      View in: PubMed
    63. Yoshida K, Sugino T, Bolodeoku J, Warren BF, Goodison S, Woodman A, Toge T, Tahara E, Tarin D. Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene. J Clin Pathol. 1996 Apr; 49(4):300-5. PMID: 8655705; PMCID: PMC500455.
    64. Higashikawa K, Yokozaki H, Ue T, Taniyama K, Ishikawa T, Tarin D, Tahara E. Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues. Int J Cancer. 1996 Mar 28; 66(1):11-7. PMID: 8608952.
      View in: PubMed
    65. Tarin D, Bolodeoku J, Hatfill SJ, Sugino T, Woodman AC, Yoshida K. The clinical significance of malfunction of the CD44 locus in malignancy. J Neurooncol. 1995 Dec; 26(3):209-19. PMID: 8750187.
      View in: PubMed
    66. Borgya A, Woodman A, Sugiyama M, Donié F, Kopetzki E, Matsumura Y, Tarin D. Isolation and characterisation of antibodies which specifically recognise the peptide encoded by exon 7 (v2) of the human CD44 gene. Clin Mol Pathol. 1995 Oct; 48(5):M241-50. PMID: 16696015.
      View in: PubMed
    67. Yoshida K, Bolodeoku J, Sugino T, Goodison S, Matsumura Y, Warren BF, Toge T, Tahara E, Tarin D. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Res. 1995 Oct 01; 55(19):4273-7. PMID: 7545538.
      View in: PubMed
    68. Matsumura Y, Sugiyama M, Matsumura S, Hayle AJ, Robinson P, Smith JC, Tarin D. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol. 1995 Sep; 177(1):11-20. PMID: 7472774.
      View in: PubMed
    69. Sugiyama M, Woodman A, Sugino T, Crowley S, Ho K, Smith J, Matsumura Y, Tarin D. Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine. Clin Mol Pathol. 1995 Jun; 48(3):M142-7. PMID: 16695995.
      View in: PubMed
    70. Quinn JM, Matsumura Y, Tarin D, McGee JO, Athanasou NA. Cellular and hormonal mechanisms associated with malignant bone resorption. Lab Invest. 1994 Oct; 71(4):465-71. PMID: 7526033.
      View in: PubMed
    71. Bao L, Matsumura Y, Baban D, Sun Y, Tarin D. Effects of inoculation site and Matrigel on growth and metastasis of human breast cancer cells. Br J Cancer. 1994 Aug; 70(2):228-32. PMID: 8054270; PMCID: PMC2033496.
    72. Tarin D, Matsumura Y. Recent advances in the study of tumour invasion and metastasis. J Clin Pathol. 1994 May; 47(5):385-90. PMID: 7517957; PMCID: PMC502010.
    73. Matsumura Y, Hanbury D, Smith J, Tarin D. Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ. 1994 Mar 05; 308(6929):619-24. PMID: 8148709; PMCID: PMC2539711.
    74. Tarin D, Matsumura Y. Deranged CD44 gene activity in malignancy. J Pathol. 1993 Dec; 171(4):249-50. PMID: 7512642.
      View in: PubMed
    75. Hayle AJ, Darling DL, Taylor AR, Tarin D. Transfection of metastatic capability with total genomic DNA from human and mouse metastatic tumour cell lines. Differentiation. 1993 Oct; 54(3):177-89. PMID: 8270145.
      View in: PubMed
    76. Baban D, Matsumura Y, Kocialkowski S, Tarin D. Studies on relationships between metastatic and non-metastatic tumor cell populations using lineages labeled with dominant selectable genetic markers. Int J Dev Biol. 1993 Mar; 37(1):237-43. PMID: 8507566.
      View in: PubMed
    77. Bao L, Pigott R, Matsumura Y, Baban D, Tarin D. Correlation of VLA-4 integrin expression with metastatic potential in various human tumour cell lines. Differentiation. 1993 Mar; 52(3):239-46. PMID: 7683291.
      View in: PubMed
    78. Tarin D, Matsumura Y. Deranged activity of the CD44 gene and other loci as biomarkers for progression to metastatic malignancy. J Cell Biochem Suppl. 1993; 17G:173-85. PMID: 7516458.
      View in: PubMed
    79. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet. 1992 Oct 31; 340(8827):1053-8. PMID: 1357452.
      View in: PubMed
    80. Matsumura Y, Tarin D. DNA fingerprinting survey of various human tumors and their metastases. Cancer Res. 1992 Apr 15; 52(8):2174-9. PMID: 1559221.
      View in: PubMed
    81. Moffett BF, Baban D, Bao L, Tarin D. Fate of clonal lineages during neoplasia and metastasis studied with an incorporated genetic marker. Cancer Res. 1992 Apr 01; 52(7):1737-43. PMID: 1551102.
      View in: PubMed
    82. Wallace JS, Hayle AJ, Syms AJ, Cairney M, Tutty B, Gazzard A, Evans MF, Fleming KA, Tarin D. The ras oncogene and tumour metastasis: observations on murine cells transfected with activated human c-Ha-ras. Differentiation. 1989 Sep; 41(3):208-15. PMID: 2693169.
      View in: PubMed
    83. Price JE, Tarin D. Low incidence of tumourigenicity in agarose colonies from spontaneous murine mammary tumours. Differentiation. 1989 Sep; 41(3):202-7. PMID: 2612768.
      View in: PubMed
    84. Juacaba SF, Horak E, Price JE, Tarin D. Tumor cell dissemination patterns and metastasis of murine mammary carcinoma. Cancer Res. 1989 Feb 01; 49(3):570-5. PMID: 2910479.
      View in: PubMed
    85. Sargent NS, Price JE, Darling DL, Flynn MP, Tarin D. Effects of altering surface glycoprotein composition on metastatic colonisation potential of murine mammary tumour cells. Br J Cancer. 1987 Jan; 55(1):21-8. PMID: 3101727; PMCID: PMC2001558.
    86. Horak E, Darling DL, Tarin D. Analysis of organ-specific effects on metastatic tumor formation by studies in vitro. J Natl Cancer Inst. 1986 May; 76(5):913-22. PMID: 3457977.
      View in: PubMed
    87. Price JE, Carr D, Tarin D. Spontaneous and induced metastasis of naturally occurring tumors in mice: analysis of cell shedding into the blood. J Natl Cancer Inst. 1984 Dec; 73(6):1319-26. PMID: 6096621.
      View in: PubMed
    88. Sargent NS, Price JE, Tarin D. Effect of enzymic removal of cell surface constituents on metastatic colonisation potential of mouse mammary tumour cells. Br J Cancer. 1983 Oct; 48(4):569-77. PMID: 6626455; PMCID: PMC2011500.
    89. Kumar RK, Price JE, Sargent NS, Tarin D. Binding of 125I-labelled concanavalin A by cells from spontaneously arising murine mammary carcinomas and experimentally induced metastases. Anticancer Res. 1983 Sep-Oct; 3(5):343-6. PMID: 6651235.
      View in: PubMed
    90. Juacaba SF, Jones LD, Tarin D. Organ preferences in metastatic colony formation by spontaneous mammary carcinomas after intra-arterial inoculation. Invasion Metastasis. 1983; 3(4):208-20. PMID: 6677627.
      View in: PubMed
    91. Tarin D, Hoyt BJ, Evans DJ. Correlation of collagenase secretion with metastatic-colonization potential in naturally occurring murine mammary tumours. Br J Cancer. 1982 Aug; 46(2):266-78. PMID: 6295423; PMCID: PMC2011086.
    92. Price JE, Carr D, Jones LD, Messer P, Tarin D. Experimental analysis of factors affecting metastatic spread using naturally occurring tumours. Invasion Metastasis. 1982; 2(2):77-112. PMID: 7188393.
      View in: PubMed
    93. Tarin D. Investigations of the mechanisms of metastatic spread of naturally occurring neoplasms. Cancer Metastasis Rev. 1982; 1(3):215-25. PMID: 6309367.
      View in: PubMed
    94. Tarin D, Price JE. Influence of microenvironment and vascular anatomy on "metastatic" colonization potential of mammary tumors. Cancer Res. 1981 Sep; 41(9 Pt 1):3604-9. PMID: 7196284.
      View in: PubMed
    95. Tarin D. Tissue interactions in morphogenesis, morphostasis and carcinogenesis. J Theor Biol. 1972 Jan; 34(1):61-72. PMID: 5017028.
      View in: PubMed